Structure and function of poly(ADP-ribose) polymerase-1: Role in oxidative stress-related pathologies

Current Vascular Pharmacology

Volumn 3, Issue 3, 2005, Pages 209-214

  Virág, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Apoptosis; Cytotoxicity; DNA damage; Necrosis; Peroxynitrite; Poly(ADP ribose) polymerase

Indexed keywords

3 AMINOBENZAMIDE; ADENOSINE DIPHOSPHATE RIBOSE; APOPTOSIS INDUCING FACTOR; DEOXYRIBONUCLEASE; DNA; GLYCOSIDASE; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; TANNIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; APOPTOSIS; ARTHRITIS; BRAIN ISCHEMIA; CATABOLISM; CELL DEATH; CELL SURVIVAL; CLINICAL TRIAL; COLITIS; CYTOTOXICITY; DERMATITIS; DIABETES MELLITUS; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; ENDOTHELIUM LESION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; GENOTOXICITY; HUMAN; INFLAMMATION; INTRACELLULAR TRANSPORT; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SEPTIC SHOCK; SHOCK; STROKE; TISSUE INJURY; TRANSCRIPTION REGULATION; UVEITIS;

ANIMALS; APOPTOSIS; ENZYME INHIBITORS; GLYCOSIDE HYDROLASES; HUMANS; NECROSIS; OXIDATIVE STRESS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES;

EID: 21644459951     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161054368625     Document Type: Review

References (69)

1. Shieh WM, Ame JC, Wilson MV, Wang ZQ, Koh DW, Jacobson MK, et al. Poly(ADP-ribose)polymerase null mouse cells synthesize ADP-ribose polymers. J Biol Chem 1998; 273:30069-30072.
2. Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M, et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 1999; 146:917-928.
3. Smith S, Giriat I, Schmitt A, de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282:1484-1487.
4. Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P, et al. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 1999; 274:17860-17868.
5. Ma Q, Baldwin KT, Renzelli AJ, McDaniel A, Dong L. TCDD-Inducible Poly(ADP-ribose) Polymerase: A Novel Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Biochem Biophys Res Commun 2001; 289:499-506.
6. Kaminker PG, Kim SH, Taylor RD, Zebarjadian Y, Funk WD, Morin GB, et al. TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J Biol Chem 2001; 276:35891-35899.
7. Augustin A, Spenlehauer C, Dumond H, Menissier-De MJ, Piel M, Schmit AC, et al. PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression. J Cell Sci 2003; 116:1551-1562.
8. Ame JC, Spenlehauer C, de MG. The PARP superfamily. Bioessays 2004; 26:882-893.
9. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54:375-429.
10. Gradwohl G, Menissier de Murcia JM, Molinete M, Simonin F, Koken M, Hoeijmakers JH, et al. The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA. Proc Natl Acad Sci USA 1990; 87:2990-2994.
11. Mazen A, Menissier-De MJ, Molinete M, Simonin F, Gradwohl G, Poirier G, et al. Poly(ADP-ribose)polymerase:a novel finger protein. Nucleic Acids Res 1989; 17:4689-4698.
12. Kanai M, Uchida M, Hanai S, Uematsu N, Uchida K, Miwa M. Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes. Biochem Biophys Res Commun 2000; 278:385-389.
13. Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, et al. Intra-mitochondrial poly(ADP-ribosylation)contributes to NAD+ depletion and cell death induced by oxidative stress. J Biol Chem 2003; 278:18426-18433.
14. Miller EG. Stimulation of nuclear poly (adenosine diphosphate-ribose) polymerase activity from HeLa cells by endonucleases. Biochim Biophys Acta 1975; 395:191-200.
15. Mendoza-Alvarez H, Alvarez-Gonzalez R. Poly(ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular. J Biol Chem 1993; 268:22575-22580.
16. Zahradka P, Ebisuzaki K. A shuttle mechanism for DNA-protein interactions. The regulation of poly(ADP-ribose) polymerasc. Eur J Biochem 1982; 127:579-585.
17. Brochu G, Duchaine C, Thibeault L, Lagueux J, Shah GM, Poirier GG. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim Biophys Acta 1994; 1219:342-350.
18. Davidovic L, Vodenicharov M, Affar EB, Poirier GG. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp Cell Res 2001; 268(1):7-13.
19. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 2001; 23:795-806.
20. Berger NA, Sims JL, Catino DM, Berger SJ. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells. Princess Takamatsu Symp 1983; 13:219-226.
21. Berger NA, Berger SJ. Metabolic consequences of DNA damage: the role of poly (ADP-ribose) polymerase as mediator of the suicide response. Basic Life Sci 1986; 38:357-363.
22. Berger SJ, Sudar DC, Berger NA. Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly (ADP-ribose) polymerase. Biochem Biophys Res Commun 1986; 134:227-232.
23. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53:3976-3985.
24. Boulares AH, Zoltoski AJ, Contreras FJ, Yakovlev AG, Yoshihara K, Smulson ME. Regulation of DNAS1L3 endonuclease activity by poly(ADP-ribosyl)ation during etoposide-induced apoptosis. Role of poly(ADP-ribose) polymerase-1 cleavage in endonuclease activation. J Biol Chem 2002; 277:372-378.
25. Yakovlev AG, Wang G, Stoica BA, Boulares HA, Spoonde AY, Yoshihara K, et al. A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase. J Biol Chem 2000; 275:21302-21308.
26. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Smulson ME. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells. Cancer Res 1999; 59:2190-2194.
27. Mendoza-Alvarez H, Alvarez-Gonzalez R. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation. J Biol Chem 2001; 276:36425-36430.
28. Simbulan-Rosenthal CM, Rosenthal DS, Ding R, Bhatia K, Smulson ME. Prolongation of the p53 response to DNA strand breaks in cells depleted of PARP by antisense RNA expression. Biochem Biophys Res Commun 1998; 253:864-868.
29. Mandir AS, Simbulan-Rosenthal CM, Poitras MF, Lumpkin JR, Dawson VL, Smulson ME, et al. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. J Neurochem 2002; 83:186-192.
30. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297:259-263.
31. Leist M, Single B, Kunstle G, Volbracht C, Hentze H, Nicotera P. Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Commun 1997; 233:518-522.
32. Virag L, Scott GS, Cuzzocrea S, Manner D, Salzman AL, Szabo C. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 1998; 94:345-355.
33. Filipovic DM, Meng X, Reeves WB. Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells. Am J Physiol 1999; 277:F428-F436.
34. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96:13978-13982.
35. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15:1983-1992.
36. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88:E14-E22.
37. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-820.
38. Garcia SF, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001; 7:108-113.
39. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404:787-790.
40. Soriano FG, Virag L, Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med 2001; 79:437-448.
41. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95:3867-3872.
42. Jijon HB, Churchill T, Malfair D, Wessler A, Jewell LD, Parsons HG, et al. Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2000; 279:G641-G651.
43. Mabley J, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virag L, et al. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm.Res.2001; 50:561-569.
44. Zingarelli B, Szabo C, Salzman AL. Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 1999; 116:335-345.
45. Szabo E, Virag L, Bakondi E, Gyure L, Hasko G, Bai P, et al. Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J Invest Dermatol 2001; 117:74-80.
46. Farkas B, Magyarlaki M, Csete B, Nemeth J, Rabloczky G, Bernath S, et al. Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor. Biochem Pharmacol 2002; 63:921-932.
47. Boulares AH, Zoltoski AJ, Sherif ZA, Jolly P, Massaro D, Smulson ME. Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 2003; 28:322-329.
48. Virag L, Bai P, Bak I, Pacher P, Mabley JG, Liaudet L, et al. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit 2004; 10:BR77-BR83.
49. Scott GS, Hake P, Kean RB, Virag L, Szabo C, Hooper DC. Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J Neuroimmunol 2001; 117:78-86.
50. Meisterernst M, Stelzer G, Roeder RG. Poly(ADP-ribose) polymerase enhances activator- dependent transcription in vitro. Proc Natl Acad Sci U S A 1997; 94:2261-2265.
51. Andreone TL, O'Connor M, Denenberg A, Hake PW, Zingarelli B. Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 2003; 170:2113-2120.
52. Ha HC. Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc Natl Acad Sci U S A 2004; 101:5087-5092.
53. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 2002; 59:1534-1553.
54. Oliver FJ, Menissier-De MJ, Nacci C, Decker P, Andriantsitohaina R, Muller S, de La Rubia G, Stoclet JC, De Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18:4446-4454.
55. Zingarelli B, Hake PW, O'Connor M, Denenberg A, Wong HR, Kong S, et al. Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol 2004; 286:H1408-H1415.
56. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. The Enzymatic and DNA Binding Activity of PARP-1 Are Not Required for NF-kappa B Coactivator Function. J Biol Chem 2001; 276:45588-45597.
57. Meyer-Ficca ML, Meyer RG, Coyle DL, Jacobson EL, Jacobson MK. Human poly(ADP-ribose)glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp Cell Res 2004; 297:521-532.
58. Ying W, Swanson RA. The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death. Neuroreport 2000; 11:1385-1388.
59. Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc Natl Acad Sci U S A 2001; 98:12227-12232.
60. Lu XC, Massuda E, Lin Q, Li W, Li JH, Zhang J. Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res 2003; 978:99-103.
61. Genovese T, Di PR, Catalano P, Li JH, Xu W, Massuda E, et al. Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit Care Med 2004; 32:1365-1374.
62. Cortes U, Tong WM, Coyle DL, Meyer-Ficca ML, Meyer RG, Petrilli V, et al. Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol Cell Biol 2004; 24:7163-7178.
63. Rapizzi E, Fossati S, Moroni F, Chiarugi A. Inhibition of poly(ADP-ribose) glycohydrolase by gallotannin selectively up-regulates expression of pro-inflammatory genes. Mol Pharmacol 2004; 66:890-898.
64. Palomba L, Sestili P, Cattabeni F, Azzi A, Cantoni O. Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cells. FEBS Lett 1996; 390:91-94.
65. Kim JW, Won J, Sohn S, Joe CO. DNA-binding activity of the N-terminal cleavage product of poly(ADP-ribose) polymerase is required for UV mediated apoptosis. J Cell Sci 2000; 113:955-961.
66. Lee YJ, Shacter E. Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 2000; 29:684-692.
67. Tronov VA, Konstantinov EM. Hydrogen peroxide-induced DNA repair and death of resting human blood lymphocytes. Biochemistry (Mosc) 2000; 65:1279-1286.
68. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, et al. Activationand caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 2002; 13:978-988.
69. Fiorillo C, Ponziani V, Giannini L, Cecchi C, Celli A, Nediani C, et al. Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation. Free Radic Res 2003; 37:331-339.